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984Objectives:Concomitant surgical atrial fibrillation (AF) ablation is a safe and feasible procedure, recommended
in guidelines. Pacemaker dependency is a known complication of AF ablation. We sought to determine
independent predictors for pacemaker implantation after surgical AF ablation.
Methods: Between January 2003 and November 2012, 594 patients underwent concomitant surgical
AF ablation. Various energy sources, including cryoablation (n ¼ 139), unipolar radiofrequency (n ¼ 278),
and bipolar radiofrequency (n ¼ 177), were used. Left atrial (n ¼ 463, 77.9%) and biatrial (n ¼ 131, 22.1%)
ablation was performed. Univariate and multivariate logistic regression analysis was used to identify
independent predictors for pacemaker implantation within 30 days after surgical AF ablation.
Results: The mean patient’s age was 68.6  9.4 years, and 66.8% were male. No major ablation-related
complications occurred. A total of 41 (6.9%) of patients received pacemaker implantation during the 30-day
follow-up period. Indications for pacemaker implantation were atrioventricular block in 25 (60.9%) of patients,
sinus bradycardia or sinus arrest in 9 (22.0%) of patients, and bradyarrhythmia in 7 (17.1%) of patients.
Demographic data, type of surgical procedure, and type of energy source did not have a significant impact on
pacemaker implantation rate. However, biatrial ablation led to a significant pacemaker implantation rate
compared with isolated left-sided ablation (6.3% vs 13.6%; P ¼ .028).
Conclusions: Concomitant surgical AF ablation showed a pacemaker implantation rate of 6.9% after 30-day
follow-up. Univariate and multivariate analysis showed biatrial lesion set as the only statistically significant
predictor for pacemaker implantation after surgical AF ablation. (J Thorac Cardiovasc Surg 2014;147:984-8)Atrial fibrillation (AF) is the most common sustaining
arrhythmia in patients undergoing heart surgery. AF is
associated with reduced atrial transport capacity and leads,
by stasis of blood in the atrium, to more thromboembolic
events, including stroke. It can, furthermore, cause heart
failure and is associated with more hospitalizations. AF
reduces quality of life and functional capacity.1-3
Treatment of AF by antiarrhythmic drugs is limited
because of significant adverse effects and poor success
rates. Therefore, concomitant surgical AF ablation is
recommended in guidelines for patients undergoing heart
surgery.4 Cox first reported his technique for surgical AF
ablation in 1987.5 The initial procedure has been modified
and resulted in the so-called Cox Maze III procedure,
which became the gold standard for surgical AF ablation
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Therefore, in recent years, the cut-and-sew technique has
been replaced by creation of transmural atrial lesions
using various thermal energy sources, which has been
termed the Cox Maze IV procedure. Energy sources
used include radiofrequency, laser, microwave, ultrasonog-
raphy, and cryoablation. The aim is the creation of
transmural lesions that block the arrhythmogenic circuits
sustaining AF. Postoperative bradycardia requiring
permanent pacemaker implantation is a known complica-
tion after surgical AF ablation. Postoperative pacemaker
implantation has been high in first reported series of the
initial Cox Maze procedure but was reduced by modifica-
tions of the initial lesion set, resulting in the so-called Cox
Maze III procedure.5 With the Cox Maze III procedure,
pacemaker implantation rates between 5% and 12%
have been reported.6,7 Gillinov8 and Cheng9 and col-
leagues have reported similar pacemaker implantation
rates for the Cox Maze IV procedure. However, there
are only few data on the influence of different lesion
sets, energy sources, and patient factors on permanent
pacemaker implantation rate after surgical AF ablation
available. Therefore, the aim of our study was to identify
independent predictors for pacemaker implantation within
30 days after concomitant surgical AF ablation.ery c March 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
LA ¼ left atrial
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DMETHODS
From January 2003 to October 2012, 594 patients underwent
concomitant surgical AF ablation due to paroxysmal (n ¼ 260, 43.8%),
persistent (n ¼ 45, 7.6%), or long-standing (n ¼ 289, 48.6%) persistent
AF. The type of ablation is shown in Table 1. Complete left atrial (LA)
ablation was performed in 323 (54.4%) of patients. Lesion set here
included pulmonary vein isolation, box lesion, LA appendage, and isthmus
isolation. Isolated bilateral pulmonary vein ablation was performed in
140 (23.6%) of patients. In patients with persistent and long-standing
persistent AF, biatrial ablation was conducted in 131 (22.1%). In addition
to the LA lesion set previously mentioned, right atrial ablation included
intercaval lesion, isolation of the cavotricuspid isthmus, the right atrial
appendage, and isolation of the terminal crest. Biatrial ablation was only
conducted in patients with persistent or long-standing persistent AF. The
decision of whether those patients received a biatrial or LA lesion set
was up to the surgeon performing the procedure.
Applied energy sources included argon-based cryoablation (CryoICE
Cryo-ablation probe [Atricure Inc, West Chester, Ohio] or Cardioblate
CryoFlex Surgical Ablation Probe [Medtronic Inc, Minneapolis, Minn)
in 139 (23.4%) of patients, unipolar radiofrequency ablation (Cardioblate
unipolar RF pen; Medtronic Inc) in 278 (46.8%) of patients and bipolar
radiofrequency ablation (Cardioblate BP2 device and Cardioblate Surgical
Ablation System Generator [Medtronic Inc] or Atricure Isolator Synergy
EML 2 [Atricure Inc]) in 177 (29.8%) of patients.
Statistical Analysis
A retrospective single-center data analysis was accomplished. All
statistical analyses were performed with SPSS statistical software, version
18.0 (SPSS Inc, Chicago, Ill). Continuous values are expressed as
mean SD and were compared with a Student t test. Categorical variables
are displayed as frequency and percentages and were compared using the
c2 test or the Fisher exact test, as appropriate. P< .05 was considered
statistically significant. The reported P values are 2 sided. Univariate and
multivariate logistic regression analysis was used to identify independent
predictors for permanent pacemaker requirement after 30 days. For
univariate analysis, the following parameters were considered: age, sex,
LA diameter, type and duration of AF, left ventricular ejection fraction,
type of surgical procedure, lesion set, and energy source. For multivariate
logistic regression analysis, significant covariates (P<.10) and covariates,
which, from our experience, had been considered as clinically relevant,
were included.
Follow-up
Documented preoperative data included age, sex, LA diameter, type and
duration of AF, left ventricular ejection fraction, type of surgical procedure,
lesion set, energy source, and comorbidities. At 30 days after surgery, data
on postoperative outcome, including mortality, stroke, and requirement for
permanent pacemaker implantation, were collected during clinical visit or
by telephone interview.RESULTS
Demographic Data
Patient characteristics are shown in Table 2. Mean patient
age was 68.6  9.6 years, and 66.8% were male. A total of
54 (9.1%) of patients had a thromboembolic or ischemicThe Journal of Thoracic and Castroke before surgery. Preoperative pacemaker was present
in 26 (4.4%) of patients.
Perioperative Data
No major ablation-related complication occurred in
any of the patients. There was no intraoperative death. In
5 (0.9%) of patients, a perioperative stroke occurred.
In-hospital mortality was 1.2%. The 30-day mortality was
2.0%, without differences between patients with and with-
out permanent pacemaker implantation (2.2% vs 2.0%).
Surgical procedures are displayed in Table 3.
Permanent Pacemaker Implantation
Permanent pacemaker implantation was required in
41 (6.9%) of 594 patients during the 30-day follow-up
period. None of these patients had an indication for
pacemaker implantation before the surgical procedure.
Indications for pacemaker insertion were atrioventricular
conduction block in 25 (4.2%), sinus bradycardia in
3 (0.5%), sinus arrest in 6 (1.0%), and bradyarrhythmia in
7 (1.2%) of patients. Generally, atrioventricular block was
the most frequent indication for pacemaker implantation in-
dependent of applied lesion set.However, there is a difference
in percentage of pacemaker implantation due to sinus node
dysfunction. In patients with a biatrial lesion set, sinus node
dysfunction was the indication for pacemaker placement in
40%, compared with 11.5%, in patients receiving only LA
lesion set (Table 4).
Requirement for permanent pacemaker implantation inpa-
tients with LA ablationwas 6.1%. In patients with biatrial le-
sion set, pacemaker implantation rate after 30-day follow-up
was statistically significantly higher in univariate and multi-
variate analysis (6.1 vs 13.6;P¼ .028) (Figure 1 andTable 5).
Different types of energy sources used had no influence on
pacemaker implantation rate after 30 days. The permanent
pacemaker implantation rates were 6.5%, 7.4%, and 6.8%
in patientswith cryoablation, unipolar radiofrequencyablation,
and bipolar radiofrequency ablation, respectively (Figure 2).
Type of surgical procedure did not affect permanent
pacemaker implantation rate after AF ablation. Although
the rate of postoperative pacemaker implantation was
slightly higher in patients receiving valve surgery
(aortic valve replacement, 8.2%; mitral valve replacement,
8.7%; tricuspid valve replacement, 7.8%) compared with
isolated coronary artery bypass grafting (5.3%), there
was no statistically significant difference. Furthermore,
demographic data and preexisting diseases had no
statistically significant influence on permanent pacemaker
implantation rate after 30-day follow-up.
Subgroup Analysis of Patients With Persistent and
Long-Standing Persistent AF
All patients receiving biatrial ablation had preoperative
persistent or long-standing persistent AF. To analyzerdiovascular Surgery c Volume 147, Number 3 985
TABLE 1. Type of ablation
Type
Patients
(n ¼ 594)
PPM
(n ¼ 41)
No PPM
(n ¼ 553)
Cryoablation 23.4 (139) 24.4 (10) 23.3 (129)
Radiofrequency 76.6 (455) 75.6 (31) 76.7 (424)
Unipolar 46.8 (278) 43.9 (18) 47.0 (260)
Bipolar 29.8 (177) 31.7 (13) 29.7 (164)
Left atrial 77.9 (463) 58.6 (24) 79.4 (439)
Biatrial 22.1 (131) 41.4 (17) 20.6 (114)
Values are given as percentage (number). PPM, Permanent pacemaker.
TABLE 3. Surgical procedures
Procedures Patients (n ¼ 594)
CABG 122 (20.5)
AVR 67 (11.3)
MVR 145 (24.4)
MVR þ CABG 50 (8.4)
AVR þ CABG 65 (10.9)
MVR þ TVR 45 (7.6)
AVR þ MVR 39 (6.6)
Others 61 (10.3)
Values are number (percentage). CABG, Coronary artery bypass graft; AVR, aortic
valve replacement; MVR, mitral valve replacement; TVR, tricuspid valve replace-
ment.
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Dwhether the higher pacemaker implantation rate was
associated rather with the type of AF or with the type of
ablation procedure, we performed a further subgroup
analysis. Pacemaker implantation rates in 203 patients
with persistent and long-standing persistent AF receiving
LA ablation were compared with those receiving biatrial
ablation. In patients with persistent or long-standing
persistent AF receiving LA ablation, the rate of pacemaker
implantation was 7.4% compared with 13.6% in patients
with biatrial ablation. The difference between the 2 groups
was statistically significant using univariate logistic
regression analysis (P ¼ .045) but not in the multivariate
analysis (P ¼ .061).DISCUSSION
Surgical AF ablation is an established procedure recom-
mended in guidelines for patients undergoing cardiac
surgery.4 Because of the simplification of the Cox Maze
III procedure by replacing the cut-and-sew principle by
transmural thermal atrial lesions, the procedure has been
used more frequently in recent years. The CoxMaze IV pro-
cedure can be performed safely, without additional risk for
morbidity and mortality in patients undergoing
cardiac surgery.9-12 There is a low incidence of severeTABLE 2. Patient characteristics
Characteristics
Patients
(n ¼ 594)
PPM
(n ¼ 41)
No PPM
(n ¼ 553)
P
value
Age, y 68.6  9.6 70.2  8.7 68.3  9.2 .20
Male sex 396 (66.8) 25 (60.9) 371 (67.1) .49
AF duration, y 3.7  3.0 3.2  3.4 3.8  3.1 .23
LA diameter, mm 49.2  8.6 50.5  7.8 49.1  8.9 .32
Paroxysmal AF 260 (43.8) 16 (39.0) 244 (44.1) .60
Persistent AF 45 (7.6) 4 (9.8) 41 (7.4) .35
Long-standing per AF 289 (48.7) 19 (46.3) 270 (45.5) .87
LVEF,% 52.5  9.8 50.8  8.4 52.8  10.2 .22
Diabetes 102 (17.2) 6 (14.6) 96 (17.4) .83
Renal insufficiency 59 (9.9) 5 (12.2) 54 (9.8) .59
Prior stroke 50 (8.4) 4 (9.8) 46 (8.3) .56
COPD 42 (7.1) 3 (7.3) 39 (7.1) .98
Values are number (percentage) unless otherwise indicated. PPM, Permanent pace-
maker; AF, atrial fibrillation; LA, left atrial; LVEF, left ventricular ejection fraction;
COPD, chronic obstructive pulmonary disease.
986 The Journal of Thoracic and Cardiovascular Surgcomplications, such as coronary artery or coronary sinus
injuries or atrioesophageal fistula, reported in the
literature.13,14 However, the permanent pacemaker
implantation rate after surgical AF ablation remained
relatively high, with rates up to 13% over the years.7,9
There are only few data available on the impact of
different lesion sets, used energy sources, and patient
factors. In our series, the additional right-sided lesion set
was a statistically independent predictor for permanent
pacemaker implantation after surgicalAFablation. One pos-
sible explanation for the higher rate of pacemaker implanta-
tion in biatrial group is that the additional right atrial lesions,
such as the intercaval connection line or the lesion towards
the tricuspid valve, might injure the sinus node and its blood
supply. The trigonum lesion, with its vicinity to the Koch tri-
angle, carries, if not conducted properly, a certain risk to in-
jure the atrioventricular node, resulting in a complete heart
block. Another possible explanation for the higher rate of
pacemaker implantation in the biatrial groupmay be the rea-
son that all patients had persistent or long-standing persis-
tent AF, which might mask a preexisting disease of the
sinus or atrioventricular node. The observation that isolated
LA lesions necessitated less pacemaker implantation seems
to support the hypothesis that postablation bradycardia is
more likely lesion related, but remains to be proved because
statistical relevance could only be calculated with univari-
ate, but not with multivariate, analysis.
A further reason for pacemaker dependency in cardiac
surgical patients may be the destruction of parasympathic
fibers, due to separation of the aorta and pulmonary artery,
leading to postoperative bradycardia in patients with
ongoing atrial fibrillation.TABLE 4. Indications for postoperative pacemaker implantation
Indication
Pacemaker all patients Left atrial Biatrial
(n ¼ 41) (n ¼ 26) (n ¼ 15)
AV block 25 (60.9) 18 (69.3) 7 (46.7)
Sinus arrest 6 (14.7) 2 (7.7) 4 (26.7)
Sinus bradycardia 3 (7.3) 1 (3.8) 2 (13.3)
Bradyarrhythmia 7 (17.1) 5 (19.2) 2 (13.3)
Values are given as number (percentage). AV, Atrioventricular.
ery c March 2014
TABLE 5. Predictors for permanent pacemaker implantation,
multivariate analysis
Predictors P value
Age .121
Male sex .212
Left atrial diameter .192
Paroxysmal AF .212
Duration of AF .092
CABG .982
AVR .092
MVR .212
TVR .232
Unipolar radiofrequency .321
Bipolar radiofrequency .231
Cryoablation .126
Biatrial lesion set .028
Left atrial lesion set .102
AF, Atrial fibrillation; CABG, coronary artery bypass graft; AVR, aortic valve replace-
ment; MVR, mitral valve replacement; TVR, tricuspid valve replacement.
FIGURE 2. Pacemaker implantation rate, according to different energy
sources. RF, Radiofrequency.
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DOne further study by Worku et al15 investigated predic-
tors for postoperative pacemaker implantation after surgical
AF ablation. In their analysis of 701 patients, the overall
pacemaker implantation rate was 7.6% within the 30-day
follow-up.13 Multivariate analysis also identified additional
right-sided lesions as an independent predictor for
permanent pacemaker requirement after surgical AF
ablation (P ¼ .039) in this study. Gillinov et al analyzed,
in their study of 575 patients, the impact of different lesion
sets on ablation success. They also reported their permanent
pacemaker implantation rate, which has been 8.7%.
However, in this analysis, patients receiving LA ablation
were grouped together with patients receiving biatrial
ablation, rendering it impossible to analyze the impactFIGURE 1. Postoperative pacemaker implantation rate, according to dif-
ferent lesion sets.
The Journal of Thoracic and Caof an additional right-sided lesion set on incidence of
pacemaker implantation after AF surgery.
Despite a higher postoperative pacemaker implantation
rate in patients with biatrial ablation, it seems worthwhile
to be considered in patients with persistent and long-
standing persistent AF, because superior results for sinus
rhythm restoration have been described, when compared
with isolated LA lesion set.8,9 However, surgeons should
keep in mind that there is always a certain risk to injure
the sinus or atrioventricular node, when performing right-
sided lesions.
Regarding different energy sources, including unipolar or
bipolar radiofrequency and cryoablation, we did not find
any differences regarding permanent pacemaker implanta-
tion. Worku et al15 identified, in their analysis, use of
microwave energy as an independent predictor for
permanent pacemaker placement, although there is no clear
explanation for this finding. They also did not see
a difference in pacemaker requirement between patients
receiving radiofrequency or cryoablation, which is consis-
tent with our finding.
We did not find further predictors for permanent
pacemaker implantation rate after surgical AF ablation.
Neither type of surgical procedure nor demographic data
or preexisting diseases had a statistically significant
influence on pacemaker placement. This finding is similar
to the findings in the study published by Worku et al.15
There are further studies reporting permanent pacemaker
implantation rates between 5.0% and 13.0% after
surgical AF ablation.7,9,16,17 However, in all of those
series, investigators just reported their overall pacemaker
implantation rate and did not look for factors associated
with pacemaker implantation. Thus, these studies do notrdiovascular Surgery c Volume 147, Number 3 987
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dependency after AF ablation.
In our opinion, the most likely reason for the higher
incidence of postoperative pacemaker implantation in
patients with biatrial ablation is the additional right-sided
lesions set with its risk to injure the sinoatrial or atrioven-
tricular node. Furthermore, a preexisting sinoatrial or
atrioventricular nodal dysfunction, which is masked by
persistent AF and appears after successful ablation, may
also play a certain role. In our study, further discrimination
between these 2 reasons is not possible. Future investiga-
tions with a prospective, randomized study design will be
needed to confirm these results.
The major limitation of the study is that we used
a nonrandomized retrospective study design in which
unknown confounders, and selection and detection bias,
cannot be completely avoided. Furthermore, this study
has been a single-center analysis.References
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